Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage.
D000328:Adult; D004912:Erythrocytes / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology*; D005955:Glucosephosphate Dehydrogenase Deficiency; D006601:Hexoses / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007773:Lactates / Q000494:pharmacology; D008297:Male; D009996:Osmotic Fragility; D010429:Pentoses / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism*; D011319:Primaquine / Q000494:pharmacology*; D011773:Pyruvates / Q000494:pharmacology
D006601:Hexoses; D007773:Lactates; D010429:Pentoses; D011773:Pyruvates; D005947:Glucose; D011319:Primaquine; D011188:Potassium